Home improvement products distributor Marwynn priced its IPO at the bottom of the range to raise $8 million at a $68 million ...

Hinge Health files for an IPO, aiming for a NYSE listing under 'HNGE' as revenue jumps 33% to $390M in 2024 and net losses narrow significantly.

After scrapping plans for an IPO in 2022, Hinge Health Inc. is taking a more favorable view of going public given the increased support seen for health care and med-tech stocks in recent months. The ...

Hinge Health files IPO with CEO Daniel Perez holding 19% voting power. Major clients include HCSC, Elevance Health & Aetna.

Hinge Health, Inc. targets a $326B market with innovative musculoskeletal care solutions. Click here to find out more about the upcoming HNGE stock IPO.

The digital health IPO market has slowed to a crawl in recent years, but it could be poised for a turnaround in 2025, experts ...

Market volatility makes listing a ‘monumental challenge.’ Meanwhile, limited partners are under pressure as distributions dry up.

South Side-based biotech firm Carmell Corp. announced a comprehensive corporate rebrand and will now operate under the new ...

Venture capitalists backing Hinge Health, which sells software to help people dealing with chronic pain, were likely cheering ...

Digital physical therapy company Hinge Health filed to go public Monday, signaling a potential revival of the dormant digital ...

Teladoc Health is offering fertility, digestive health, and specialty care to its enterprise customers, the company said ...

Wall Street is working to usher a highly-anticipated group of companies to the public markets, but rampant volatility and a ...